Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Peter Impey

- PMLiVE

Novo Nordisk’s semaglutide obesity trial hits the mark

The injection helped adults lose up to 13.8% of their body weight in a year

- PMLiVE

New data could put Roche’s Tecentriq first in squamous lung cancer

NSCLC patients on the drug saw a reduced risk of disease progression

- PMLiVE

Mundipharma adds breast cancer biosimilar to its portfolio with Celltrion deal

Will launch Herzuma in seven European countries including the UK and Germany

- PMLiVE

Parexel appoints CEO

Jamie Macdonald succeeds co-founder Josef von Rickenbach

Metrion Biosciences adds to its board

Dr Barry Kenny and Dr Andrew Southan join the company

The rise of real-world evidence

Demonstrating efficacy and value requires more than clinical trial data

- PMLiVE

IQVIA partners with Box

Will work on managing content for the life science industry

- PMLiVE

Lundbeck signs $1.1bn deal for Prexton and Parkinson’s drug

Foliglurax is currently in phase II testing for LID, muscle stiffness and ‘freezing’

- PMLiVE

EMA starts review of Xtandi in non-metastatic prostate cancer

The evaluation is based on positive results from the PROSPER trial

Lighthouse bolsters its US senior scientific team

Marc Pondel joins the agency as executive medical science director

- PMLiVE

HAVAS SO appoints director of SO Creative

James March will lead the SO Creative advertising team

Digital health

The untapped potential to transform healthcare

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links